Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KKR & Co
KKR
|
+$705M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$675M |
| 3 |
Zoetis
ZTS
|
+$510M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$404M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$538M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$397M |
| 3 |
RTX Corp
RTX
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$332M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.69% |
| 2 | Technology | 9.44% |
| 3 | Healthcare | 8.03% |
| 4 | Consumer Discretionary | 7.35% |
| 5 | Communication Services | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
DexCom
DXCM
$31.8B
| $177M | 0.05% |
8,371,848
+1,278,524
| +18% | +$25M |
|
|
MIC
352
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $176M | 0.05% |
2,184,723
-148,803
| -6% | -$11.8M |
|
353
Tanger
SKT
$4.7B
| $175M | 0.05% |
5,353,601
+477,744
| +10% | +$16.2M |
|
354
PNC Financial Services
PNC
$100B
| $175M | 0.05% |
1,452,181
-84,232
| -5% | -$10.3M |
|
355
Starwood Property Trust
STWD
$5.94B
| $174M | 0.05% |
7,697,546
-162,996
| -2% | -$3.68M |
|
|
HCR
356
DELISTED
Hi-Crush Inc. Common Stock
HCR
| $174M | 0.05% |
10,011,999
+1,633,971
| +20% | +$30.2M |
|
357
Apollo Global Management
APO
$71.5B
| $173M | 0.05% |
7,111,844
-1,199,631
| -14% | -$26.7M |
|
358
First Trust Nasdaq Bank ETF
FTXO
$306M
| $173M | 0.05% |
+6,658,594
| New | +$177M |
|
|
MJN
359
DELISTED
Mead Johnson Nutrition Company
MJN
| $173M | 0.05% |
1,939,244
+1,251,041
| +182% | +$103M |
|
360
Palo Alto Networks
PANW
$267B
| $172M | 0.05% |
9,184,926
-1,240,176
| -12% | -$27.7M |
|
|
HR
361
DELISTED
Healthcare Realty Trust Incorporated
HR
| $172M | 0.05% |
5,297,551
+1,822,804
| +52% | +$56.4M |
|
362
GSK
GSK
$104B
| $172M | 0.05% |
3,262,608
-428,826
| -12% | -$21.8M |
|
363
Bread Financial
BFH
$4.37B
| $172M | 0.05% |
863,184
+547,047
| +173% | +$103M |
|
364
iShares Currency Hedged MSCI EAFE ETF
HEFA
$7.51B
| $172M | 0.05% |
6,232,497
+1,161,329
| +23% | +$31.2M |
|
365
Sanofi
SNY
$103B
| $170M | 0.05% |
3,764,318
-431,510
| -10% | -$18.3M |
|
366
iShares MBS ETF
MBB
$38.9B
| $169M | 0.05% |
1,589,916
+88,381
| +6% | +$9.39M |
|
367
NOV
NOV
$6.84B
| $169M | 0.05% |
4,218,392
+1,124,578
| +36% | +$43.8M |
|
|
VAL
368
DELISTED
Valspar
VAL
| $169M | 0.05% |
1,522,448
-107,941
| -7% | -$11.9M |
|
369
Nucor
NUE
$58.5B
| $167M | 0.05% |
2,788,254
-338,045
| -11% | -$20.7M |
|
370
Sherwin-Williams
SHW
$82.7B
| $166M | 0.05% |
1,606,695
-420,438
| -21% | -$42.3M |
|
371
Cardinal Health
CAH
$53.6B
| $166M | 0.05% |
2,035,339
+402,151
| +25% | +$31.7M |
|
372
Elevance Health
ELV
$82.1B
| $164M | 0.05% |
993,502
+142,818
| +17% | +$22.7M |
|
373
Paychex
PAYX
$41.4B
| $164M | 0.05% |
2,786,888
+601,496
| +28% | +$36.6M |
|
|
LXFT
374
DELISTED
Luxoft Holding, Inc.
LXFT
| $164M | 0.05% |
2,623,017
+159,716
| +6% | +$9.4M |
|
|
BWP
375
DELISTED
Boardwalk Pipeline Partners
BWP
| $163M | 0.05% |
8,925,784
+447,888
| +5% | +$8.16M |
|
Similar funds
Morgan Stanley's Q1 2017 Portfolio in Review
As of Q1 2017, Morgan Stanley held 6,814 positions worth $325B, up 6.5% from $306B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q1 2017 filing shows 216 new, 2,666 increased, 3,277 reduced and 152 closed positions. Its largest new stake was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M. The largest sale was St Jude Medical, an estimated $538M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 9.9% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2017 buy was First Trust Nasdaq Bank ETF: 6,658,594 shares worth $173M.
- Morgan Stanley added most to KKR & Co in Q1 2017, an estimated $705M increase.
- Morgan Stanley's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $397M.
- Morgan Stanley fully exited St Jude Medical in Q1 2017, selling an estimated $538M.
- Morgan Stanley's ten largest holdings make up 12% of its $325B portfolio in Q1 2017.
- Morgan Stanley opened 216 new positions and closed 152 in Q1 2017.
- Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $325B.
Based on Morgan Stanley's 13F filing for Q1 2017, filed 12 May 2017.